← Back to headlines
Gilead (GILD) and Tempus AI (TEM) Expand Oncology R&D Collaboration
Gilead (GILD) and Tempus AI (TEM) have announced an expansion of their multi-year collaboration in oncology research and development.
12 Apr, 18:43 — 12 Apr, 18:43
Sources
Showing 1 of 1 sources
